Histone chaperone ASF1A
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein heterocomplex Heteromer Protein × 2 PDB declaration: dimeric(2) Consistent with protein copy count | Chain A; UniProt 1–156 | Not recorded | ip2_s × 1 | X-RAY DIFFRACTION X-ray crystallization conditions:EVAPORATION;pH 7.5;298 K;Tris-HCl 0.1M pH7.5, PEG8000 5% | Resolution 2.00 Å R-free 0.227 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 6F0F | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1TEY NMR structure of human histone chaperone, ASF1A Deposited 2004-05-26 | Different construct Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–156(156 aa)
Fragment:N-TERMINAL DOMAIN (residues 1-156)
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7.4;298 K;Ionic strength (raw mmCIF value) 20 mM;Pressure ambient
NMR sample composition
1mM Asf1A U-15N,13C; 20mM tris-D11; 1mM EDTA; 0.1mM DSS; 0.1 mM NaN3; 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2I32 Structure of a human ASF1a-HIRA complex and insights into specificity of histone chaperone complex assembly Deposited 2006-08-17 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–157(157 aa)
Fragment:Residues 1-157
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;298 K;CRYSTALS OF THE HUMAN ASF1AN-HIRA(425-472) COMPLEX WERE
GROWN BY HANGING DROP VAPOR DIFFUSION AT ROOM TEMPERATURE
AND WERE OBTAINED BY MIXING 2 UL OF A 0.5 MM PROTEIN
COMPLEX SOLUTION (IN 20 MM HEPES PH 7.0, 150 MM NACL AND
5 MM BETA-ME) WITH 2 UL OF RESERVOIR SOLUTION CONTAINING
1.44 M NAH2PO4 AND 0.16 M K2HPO4 AT PH 5.6, AND
EQUILIBRATING OVER 1.0 ML OF RESERVOIR SOLUTION. CRYSTALS
WERE FULLY GROWN WITHIN TWO WEEKS TO A TYPICAL SIZE OF
0.3MMX0.3MMX0.2MM, VAPOR DIFFUSION, HANGING DROP,
TEMPERATURE 298.0K
|
Resolution 2.70 Å R-free 0.269 |
| 2I32 Structure of a human ASF1a-HIRA complex and insights into specificity of histone chaperone complex assembly Deposited 2006-08-17 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1–157(157 aa)
Fragment:Residues 1-157
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;298 K;CRYSTALS OF THE HUMAN ASF1AN-HIRA(425-472) COMPLEX WERE
GROWN BY HANGING DROP VAPOR DIFFUSION AT ROOM TEMPERATURE
AND WERE OBTAINED BY MIXING 2 UL OF A 0.5 MM PROTEIN
COMPLEX SOLUTION (IN 20 MM HEPES PH 7.0, 150 MM NACL AND
5 MM BETA-ME) WITH 2 UL OF RESERVOIR SOLUTION CONTAINING
1.44 M NAH2PO4 AND 0.16 M K2HPO4 AT PH 5.6, AND
EQUILIBRATING OVER 1.0 ML OF RESERVOIR SOLUTION. CRYSTALS
WERE FULLY GROWN WITHIN TWO WEEKS TO A TYPICAL SIZE OF
0.3MMX0.3MMX0.2MM, VAPOR DIFFUSION, HANGING DROP,
TEMPERATURE 298.0K
|
Resolution 2.70 Å R-free 0.269 |
| 3AAD Structure of the histone chaperone CIA/ASF1-double bromodomain complex linking histone modifications and site-specific histone eviction Deposited 2009-11-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain B
1–155(155 aa)
Fragment:Residues 1-155
Chain D
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.65;293 K;0.1M MES, 1.1M AMMONIUM SULFATE, 0.25M LITHIUM SULFATE, pH 5.65, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.30 Å R-free 0.293 |
| 5C3I Crystal structure of the quaternary complex of histone H3-H4 heterodimer with chaperone ASF1 and the replicative helicase subunit MCM2 Deposited 2015-06-17 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain I
1–175(175 aa)
Fragment:UNP residues 1-175
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;289 K;20% PEG 3350, 2% Tacsimate,0.1 M Tris-HCl pH 8.0
|
Resolution 3.50 Å R-free 0.253 |
| 5C3I Crystal structure of the quaternary complex of histone H3-H4 heterodimer with chaperone ASF1 and the replicative helicase subunit MCM2 Deposited 2015-06-17 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–175(175 aa)
Fragment:UNP residues 1-175
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;289 K;20% PEG 3350, 2% Tacsimate,0.1 M Tris-HCl pH 8.0
|
Resolution 3.50 Å R-free 0.253 |
| 5C3I Crystal structure of the quaternary complex of histone H3-H4 heterodimer with chaperone ASF1 and the replicative helicase subunit MCM2 Deposited 2015-06-17 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain E
1–175(175 aa)
Fragment:UNP residues 1-175
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;289 K;20% PEG 3350, 2% Tacsimate,0.1 M Tris-HCl pH 8.0
|
Resolution 3.50 Å R-free 0.253 |
| 5C3I Crystal structure of the quaternary complex of histone H3-H4 heterodimer with chaperone ASF1 and the replicative helicase subunit MCM2 Deposited 2015-06-17 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain M
1–175(175 aa)
Fragment:UNP residues 1-175
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;289 K;20% PEG 3350, 2% Tacsimate,0.1 M Tris-HCl pH 8.0
|
Resolution 3.50 Å R-free 0.253 |
| 5C3I Crystal structure of the quaternary complex of histone H3-H4 heterodimer with chaperone ASF1 and the replicative helicase subunit MCM2 Deposited 2015-06-17 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain Q
1–175(175 aa)
Fragment:UNP residues 1-175
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;289 K;20% PEG 3350, 2% Tacsimate,0.1 M Tris-HCl pH 8.0
|
Resolution 3.50 Å R-free 0.253 |
| 5C3I Crystal structure of the quaternary complex of histone H3-H4 heterodimer with chaperone ASF1 and the replicative helicase subunit MCM2 Deposited 2015-06-17 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain U
1–175(175 aa)
Fragment:UNP residues 1-175
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;289 K;20% PEG 3350, 2% Tacsimate,0.1 M Tris-HCl pH 8.0
|
Resolution 3.50 Å R-free 0.253 |
| 6F0G Crystal structure ASF1-ip3 Deposited 2017-11-20 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–156(156 aa)
|
Not recorded | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Citrate 0.1M pH 2.5, LiSO4 0.25M, PEG8000 7%
|
Resolution 2.30 Å R-free 0.267 |
| 6F0G Crystal structure ASF1-ip3 Deposited 2017-11-20 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1–156(156 aa)
|
Not recorded | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Citrate 0.1M pH 2.5, LiSO4 0.25M, PEG8000 7%
|
Resolution 2.30 Å R-free 0.267 |
| 6F0H Crystal structure ASF1-ip4 Deposited 2017-11-20 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain A
1–156(156 aa)
Chain C
1–156(156 aa)
|
Not recorded | SO4 SULFATE ION × 12 GOL GLYCEROL × 6 CIT CITRIC ACID × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Citrate 0.1M pH 2.5, LiSO4 0.5M, PEG8000 10%
|
Resolution 1.98 Å R-free 0.242 |
| 6ZUF Urea-based Foldamer Inhibitor chimera C2 in complex with ASF1 Histone chaperone Deposited 2020-07-22 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–156(156 aa)
|
Not recorded | GOL GLYCEROL × 3 SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.2;293 K;100 mM Sodium Citrate pH4.2, 300 mM LiSO4, 26% PEG3350
|
Resolution 1.80 Å R-free 0.210 |
| 6ZUF Urea-based Foldamer Inhibitor chimera C2 in complex with ASF1 Histone chaperone Deposited 2020-07-22 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1–156(156 aa)
|
Not recorded | GOL GLYCEROL × 6 SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.2;293 K;100 mM Sodium Citrate pH4.2, 300 mM LiSO4, 26% PEG3350
|
Resolution 1.80 Å R-free 0.210 |
| 7LNY Apo structure of the Histone chaperone ASF1A residues 1-155 Deposited 2021-02-08 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;1 ml reservoir of 22% PEG3350 and 6% of Tascimate pH6.0
|
Resolution 2.10 Å R-free 0.242 |
| 7LNY Apo structure of the Histone chaperone ASF1A residues 1-155 Deposited 2021-02-08 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;1 ml reservoir of 22% PEG3350 and 6% of Tascimate pH6.0
|
Resolution 2.10 Å R-free 0.242 |
| 7LNY Apo structure of the Histone chaperone ASF1A residues 1-155 Deposited 2021-02-08 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain C
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;1 ml reservoir of 22% PEG3350 and 6% of Tascimate pH6.0
|
Resolution 2.10 Å R-free 0.242 |
| 7LNY Apo structure of the Histone chaperone ASF1A residues 1-155 Deposited 2021-02-08 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain D
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;1 ml reservoir of 22% PEG3350 and 6% of Tascimate pH6.0
|
Resolution 2.10 Å R-free 0.242 |
| 7LNY Apo structure of the Histone chaperone ASF1A residues 1-155 Deposited 2021-02-08 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 5 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain E
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;1 ml reservoir of 22% PEG3350 and 6% of Tascimate pH6.0
|
Resolution 2.10 Å R-free 0.242 |
| 7LNY Apo structure of the Histone chaperone ASF1A residues 1-155 Deposited 2021-02-08 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 6 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain F
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;1 ml reservoir of 22% PEG3350 and 6% of Tascimate pH6.0
|
Resolution 2.10 Å R-free 0.242 |
| 7LNY Apo structure of the Histone chaperone ASF1A residues 1-155 Deposited 2021-02-08 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 7 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain G
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;1 ml reservoir of 22% PEG3350 and 6% of Tascimate pH6.0
|
Resolution 2.10 Å R-free 0.242 |
| 7LO0 Structure of human ASF1a in complex with a TLK2 peptide Deposited 2021-02-08 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG3350, 0.2 M of trisodium citrate, pH 5.6 and 2% Octyl-D-glucose
|
Resolution 2.71 Å R-free 0.226 |
| 7LO0 Structure of human ASF1a in complex with a TLK2 peptide Deposited 2021-02-08 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain B
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG3350, 0.2 M of trisodium citrate, pH 5.6 and 2% Octyl-D-glucose
|
Resolution 2.71 Å R-free 0.226 |
| 7LO0 Structure of human ASF1a in complex with a TLK2 peptide Deposited 2021-02-08 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG3350, 0.2 M of trisodium citrate, pH 5.6 and 2% Octyl-D-glucose
|
Resolution 2.71 Å R-free 0.226 |
| 7LO0 Structure of human ASF1a in complex with a TLK2 peptide Deposited 2021-02-08 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain D
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG3350, 0.2 M of trisodium citrate, pH 5.6 and 2% Octyl-D-glucose
|
Resolution 2.71 Å R-free 0.226 |
| 7LO0 Structure of human ASF1a in complex with a TLK2 peptide Deposited 2021-02-08 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain E
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG3350, 0.2 M of trisodium citrate, pH 5.6 and 2% Octyl-D-glucose
|
Resolution 2.71 Å R-free 0.226 |
| 7LO0 Structure of human ASF1a in complex with a TLK2 peptide Deposited 2021-02-08 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain F
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG3350, 0.2 M of trisodium citrate, pH 5.6 and 2% Octyl-D-glucose
|
Resolution 2.71 Å R-free 0.226 |
| 7LO0 Structure of human ASF1a in complex with a TLK2 peptide Deposited 2021-02-08 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 7 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain G
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG3350, 0.2 M of trisodium citrate, pH 5.6 and 2% Octyl-D-glucose
|
Resolution 2.71 Å R-free 0.226 |
| 7LO0 Structure of human ASF1a in complex with a TLK2 peptide Deposited 2021-02-08 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 8 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain H
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG3350, 0.2 M of trisodium citrate, pH 5.6 and 2% Octyl-D-glucose
|
Resolution 2.71 Å R-free 0.226 |
| 7V6Q Crystal structure of sNASP-ASF1A-H3.1-H4 complex Deposited 2021-08-20 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–156(156 aa)
|
Not recorded | GOL GLYCEROL × 4 1PE PENTAETHYLENE GLYCOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;18% (v/v) Tacsimate, pH 5.0
11% (v/v) PEG2000MME
|
Resolution 3.00 Å R-free 0.203 |
| 7V6Q Crystal structure of sNASP-ASF1A-H3.1-H4 complex Deposited 2021-08-20 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain E
1–156(156 aa)
|
Not recorded | GOL GLYCEROL × 2 1PE PENTAETHYLENE GLYCOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;18% (v/v) Tacsimate, pH 5.0
11% (v/v) PEG2000MME
|
Resolution 3.00 Å R-free 0.203 |
| 8BV1 Peptide inhibitor P4 in complex with ASF1 histone chaperone Deposited 2022-12-01 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–156(156 aa)
|
Not recorded | GOL GLYCEROL × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290.15 K;0.1 M Tris pH 8.5
30% (w/v) PEG 400
|
Resolution 2.83 Å R-free 0.221 |
| 8BV1 Peptide inhibitor P4 in complex with ASF1 histone chaperone Deposited 2022-12-01 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1–156(156 aa)
|
Not recorded | GOL GLYCEROL × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290.15 K;0.1 M Tris pH 8.5
30% (w/v) PEG 400
|
Resolution 2.83 Å R-free 0.221 |
| 8BV1 Peptide inhibitor P4 in complex with ASF1 histone chaperone Deposited 2022-12-01 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
1–156(156 aa)
|
Not recorded | GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290.15 K;0.1 M Tris pH 8.5
30% (w/v) PEG 400
|
Resolution 2.83 Å R-free 0.221 |
| 8BV1 Peptide inhibitor P4 in complex with ASF1 histone chaperone Deposited 2022-12-01 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
1–156(156 aa)
|
Not recorded | GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290.15 K;0.1 M Tris pH 8.5
30% (w/v) PEG 400
|
Resolution 2.83 Å R-free 0.221 |
| 8BV1 Peptide inhibitor P4 in complex with ASF1 histone chaperone Deposited 2022-12-01 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain E
1–156(156 aa)
|
Not recorded | GOL GLYCEROL × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290.15 K;0.1 M Tris pH 8.5
30% (w/v) PEG 400
|
Resolution 2.83 Å R-free 0.221 |
| 8BV1 Peptide inhibitor P4 in complex with ASF1 histone chaperone Deposited 2022-12-01 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain F
1–156(156 aa)
|
Not recorded | GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290.15 K;0.1 M Tris pH 8.5
30% (w/v) PEG 400
|
Resolution 2.83 Å R-free 0.221 |
| 8CJ1 Urea-based foldamer inhibitor c3u_3 chimera in complex with ASF1 histone chaperone Deposited 2023-02-11 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain A
1–156(156 aa)
Chain B
1–156(156 aa)
Chain C
1–156(156 aa)
Chain D
1–156(156 aa)
Chain E
1–156(156 aa)
Chain F
1–156(156 aa)
Chain G
1–156(156 aa)
Chain H
1–156(156 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;290.15 K;0.1 M MES pH 6.5
40% (w/v) PEG 200
|
Resolution 2.56 Å R-free 0.280 |
| 8CJ2 Urea-based foldamer inhibitor c3u_5 chimera in complex with ASF1 histone chaperone Deposited 2023-02-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric |
Chain A
1–156(156 aa)
Chain B
1–156(156 aa)
Chain C
1–156(156 aa)
Chain D
1–156(156 aa)
|
Not recorded | GOL GLYCEROL × 14 SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.6;290.15 K;0.17 M ammonium sulfate
0.085 M NaOAc pH 4.6
25.5% PEG 2000 MME
15% (v/v) glycerol
|
Resolution 2.13 Å R-free 0.215 |
| 8CJ3 Urea-based foldamer inhibitor c3u_7 chimera in complex with ASF1 histone chaperone Deposited 2023-02-11 | Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–156(156 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;290.15 K;0.2 M potassium fluoride
20% (w/v) PEG 3350
|
Resolution 3.00 Å R-free 0.217 |
| 8Z50 Crystal structure of the ASF1-H3T-H4 complex Deposited 2024-04-18 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
1–173(173 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;1.0 M Lithium chloride, 0.1 M MES pH 6.0, 10% PEG 6000
|
Resolution 2.80 Å R-free 0.255 |
| 9CVC CDAN1 dimer with three ASF1A Deposited 2024-07-29 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain C
1–204(204 aa)
Chain D
1–204(204 aa)
Chain E
1–204(204 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å |
| 9IMZ CODANIN-1 sequesters ASF1 by using a histone H3 mimic helix to regulate histone supply Deposited 2024-07-05 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain C
1–172(172 aa)
Chain D
1–172(172 aa)
Chain E
1–172(172 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.75 Å |
17 other PDB entries and 44 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | ASF1A_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 3–158; UniProt 1–156 |